MobiHealth News May 24, 2024
Jessica Hagen

The continuous glucose monitoring biosensor platform will use the funds to scale its manufacturing, move toward regulatory approval and perform more clinical trials.

California-based Allez Health, formerly Zense-Life, announced it secured $60 million in Series A+ financing.

The round was led by strategic investor Osang Healthcare, with participation from existing investors.

WHAT IT DOES

Allez Health is a continuous glucose monitoring biosensor platform that uses sensor technology to improve a patient’s performance by analyzing datasets across various health afflictions.

The funding will be used to support operations and regulatory approval filings, scale manufacturing and accelerate clinical trials.

The company’s cofounders and leadership team are made up of former Dexcom leaders.

Allez Health’s chief executive officer, Leif...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Investments, Technology, Trends, Wearables
Apple Watch to Use Mass 3D Printed Metal Parts from China’s Bright Laser Technologies
Apple analyst Kuo says new Apple Watch will include larger screen, thinner design
RingConn Smart Ring Review
The Smart Sleep Alarm Is The Holy Grail Of Health Tracking
The opportunity to save payers money and scale access to care

Share This Article